Last reviewed · How we verify

NCT04122820: TDys

Ambulatory Screening for Specific Learning Disabilities (SLD) and Developmental Coordination Disorder (DCD).

Status unknown NA Last updated 18 October 2019
What this trial tests

NA trial testing Diagnostic of specific learning disabilities or of Developmental Coordination Disorder in Specific Developmental Disorders of Speech and Language in 1,800 participants. Status unknown.

Timeline
16 October 2019
Primary endpoint
30 October 2021
30 October 2022

Quick facts

Lead sponsorCNGE IRMG Association
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposescreening
Enrollment1,800
Start date16 October 2019
Primary completion30 October 2021
Estimated completion30 October 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

CNGE IRMG Association

Who can join

Adults 8 to 12, any sex, with Specific Developmental Disorders of Speech and Language or Specific Learning Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate, in primary care, the sensitivity of Heterophory-Vertical-Labile (HV-Labile) in ambulatory screening for Specific Learning Disabilities (SLD) and Developmental Coordination Disorder (DCD). in children aged 8 to 12 years.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04122820.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing